Jury Awards $285,000 in Bellwether Fosamax Lawsuit

Jury Awards $285,000 in Bellwether Fosamax Lawsuit 

This past Monday, a New York federal judge denied Big Pharma’s Merck & Co Inc.’s attempt to avoid paying $285,000 to plaintiff in a multi-district lawsuit based on the fact that the bone drug Fosamax causes jaw deterioration. Merck’s argument was that its warning label was adequate, but the judge didn’t buy it.

Read the rest of this blog post at ReyesLaw.com
Trackbacks (0) Links to blogs that reference this article Trackback URL
Comments (0) Read through and enter the discussion with the form at the end

Angel Reyes on Twitter


most recent Twitter posts
    My Book Hispanic Heresy book

    Order a copy

    Latest Videos